Association between serum advanced oxidation protein products and mortality risk in maintenance hemodialysis patients

BackgroundThe association between serum advanced oxidation protein products (AOPP) and mortality risk remains equivocal. We aimed to assess the correlation of serum AOPP levels with the risk of all-cause mortality in hemodialysis (HD) patients.MethodsA total of 1394 maintenance HD patients with complete data on AOPP and related parameters were included from China Collaborative Study on Dialysis (CCSD), a multi-center, prospective cohort study. The primary outcome was all-cause mortality, the secondary outcome was cardiovascular disease (CVD) mortality.ResultsDuring a median follow-up duration of 5.2 years (IQR, 2.1-5.4), all-cause mortality occurred in 492 (31.4%) participants. Overall, there was a reversed L-shaped association between serum AOPP and all-cause mortality in HD patients (P for nonlinearity=0.04), with an inflection point at 87 mu mol/L. Accordingly, there was no significant association between serum AOPP and all-cause mortality (per SD increment; HR, 0.94; 95%CI, 0.84, 1.05) in participants with AOPP<87 mol/L. However, there was a positive relationship of serum AOPP and all-cause mortality (per SD increment; HR, 1.24; 95%CI, 1.08, 1.42) in those with AOPP >= 87 mu mol/L. Moreover, a similar trend was found for CVD mortality.ConclusionsElevated serum AOPP levels were associated with higher risk of all-cause mortality in Chinese maintenance HD patients.

Automated summary

This study aimed to assess the correlation of serum advanced oxidation protein products (AOPP) levels with the risk of all-cause mortality in hemodialysis (HD) patients in China. The results showed that elevated serum AOPP levels were associated with a higher risk of all-cause mortality in Chinese maintenance HD patients, particularly in those with AOPP levels >=87 mu mol/L.